(PharmaNewsWire.Com, September 21, 2017 ) The Europe Platelet Aggregation Devices Market was worth USD 41.6 million in 2016 and is estimated to be growing at a CAGR of 22.3%, to reach USD 113.8 million by 2021. Platelets are one of the components of blood. They are responsible for the formation of thrombus in the blood. Platelets arrive at the site of injury; they clump together and form as a blood clot.
The process by which platelets clump together at the site of the injury is called platelet aggregation. Platelet disorders are increasing in number either due to hereditary reasons or due to some other disease. People with these disorders are unable to form blood clots resulting uncontrolled bleeding in case of injuries. Platelet aggregation devices are available in the market as a solution to these disorders. They can control the aggregation process and help in the clot formation.
Rising number of cardiovascular surgeries, new technological advances in platelet aggregators and increase in clinical studies are the propelling the market growth. Increasing number of orthopedic and bleeding disorders are also driving the market. Strict regulations and absence of skilled professionals are restraining the market growth.
The Europe market for platelet aggregation devices is segmented by product, applications, end user and by region. Based on product, the market is segmented into systems, reagents and consumables and accessories. Platelet aggregation systems hold the largest market share due to the increasing automation of aggregation testing procedures. Based on application, the market is segmented into clinical applications and research applications. Clinical applications are again segmented into cardiovascular applications, orthopedic applications and other clinical applications. Clinical applications segment holds the largest market share due to the increased adoption of aggregator devices by healthcare professionals. Based on end user, the market is segmented into standalone hospitals, diagnostic laboratories, research and academic institutes and other end users. Standalone hospitals are expected to hold the largest market share in end users segment due to the increase in platelet disorders and increasing use of platelet therapy for cancer patients.
Based on region, Europe platelet aggregation market is segmented into UK, Germany, France, Spain and Italy. Europe holds the second largest market share next to North America. It is due to availability of affordable platelet function tests and developing distribution channels.
Major companies in the Europe platelet aggregation devices market are Sentinel CH. S.p.A., Helena Laboratories Corporation, Siemens AG, Haemonetics Corporation, Sysmex Corporation, Accriva Diagnostics, Bio/Data Corporation, Tem Group and Aggredyne, Inc.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
